STRIDES PHARMA SCIENCE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 839.4 INR | -4.79% |
|
-6.37% | +29.45% |
| 04-30 | Strides Pharma Science Limited Approves Appointment of Ameet P Hariani as Independent Director | CI |
| 04-09 | Strides Pharma Science Gets US FDA Nod for Fluoxetine Tabs | MT |
Evolution of the average Target Price on Strides Pharma Science Limited
Price target over the last 5 years
History of analyst recommendation changes
6881c0c0baffe26ee401.U3pGEiv7jZu-cvVJY_r-pYUFrAa0pWA0WQaLgahot8A.KSMfZF6O--n_OZgEEreO8O9kn17F7jpwM0Lj1O4J7oIVHX5-bLn3qPZCmg~57d70420f47dda238500fb240f09aec1
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
839.4
INR
Average target price
830.5
INR
Spread / Average Target
-1.06%
High Price Target
965
INR
Spread / Highest target
+14.96%
Low Price Target
710
INR
Spread / Lowest Target
-15.42%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- STAR Stock
- STAR Stock
- Consensus Strides Pharma Science Limited